Cargando…

Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies

In vitro modeling of hematological malignancies not only provides insights into the influence of genetic aberrations on cellular and molecular mechanisms involved in disease progression but also aids development and evaluation of therapeutic agents. Owing to their self-renewal and differentiation ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sidhu, Ishnoor, Barwe, Sonali P., Pillai, Raju K., Gopalakrishnapillai, Anilkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534597/ https://www.ncbi.nlm.nih.gov/pubmed/34685678 http://dx.doi.org/10.3390/cells10102698

Ejemplares similares

Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology
por: Barwe, Sonali P., et al.
Publicado: (2020)

Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of GATA1 and STAG2 Mutations in Induced Pluripotent Stem Cells with Trisomy 21
por: Barwe, Sonali P., et al.
Publicado: (2022)

Tetraspanins set the stage for bone marrow microenvironment–induced chemoprotection in hematologic malignancies
por: Quagliano, Anthony, et al.
Publicado: (2023)

Metformin suppresses pediatric acute myeloid leukemia cell viability and clonogenicity
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2014)

Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer
por: Quagliano, Anthony, et al.
Publicado: (2020)

Imetelstat Induces Leukemia Stem Cell Death in Pediatric Acute Myeloid Leukemia Patient-Derived Xenografts
por: Barwe, Sonali P., et al.
Publicado: (2022)

Bone Marrow Microenvironment-Induced Chemoprotection in KMT2A Rearranged Pediatric AML Is Overcome by Azacitidine–Panobinostat Combination
por: Lehner, Kara M., et al.
Publicado: (2023)

Mesothelin: An Immunotherapeutic Target beyond Solid Tumors
por: Faust, Joshua R., et al.
Publicado: (2022)

Disruption of Annexin II /p11 Interaction Suppresses Leukemia Cell Binding, Homing and Engraftment, and Sensitizes the Leukemia Cells to Chemotherapy
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2015)

Efficacy of Flotetuzumab in Combination with Cytarabine in Patient-Derived Xenograft Models of Pediatric Acute Myeloid Leukemia
por: Barwe, Sonali P., et al.
Publicado: (2022)

Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2016)

Error-corrected sequencing strategies enable comprehensive detection of leukemic mutations relevant for diagnosis and minimal residual disease monitoring
por: Crowgey, Erin L., et al.
Publicado: (2020)

HARNESSING THE HEALING POWER OF WESTERN AND NON-WESTERN HEALERS: IMPLICATIONS FOR SOCIAL WORK PRACTICE
por: Gupta, Rashmi, et al.
Publicado: (2019)

Harnessing the Potential of Human Pluripotent Stem Cells and Gene Editing for the Treatment of Retinal Degeneration
por: Ovando-Roche, Patrick, et al.
Publicado: (2017)

Harnessing CRISPR-Cas system diversity for gene editing technologies
por: McKay, Alexander, et al.
Publicado: (2021)

Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease
por: Limanskiy, Viktor, et al.
Publicado: (2019)

Harnessing the power of the Grid
Publicado: (2009)

Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies
por: Chakraborty, Nayanika, et al.
Publicado: (2022)

Harnessing the Power of Defensive Microbes: Evolutionary Implications in Nature and Disease Control
por: Ford, Suzanne A., et al.
Publicado: (2016)

Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases
por: Li, Mailin, et al.
Publicado: (2017)

Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy
por: Allegra, Alessandro, et al.
Publicado: (2022)

Harnessing the power of the plasma wakefield
Publicado: (2007)

Harnessing the power of neuroplasticity for intervention
por: Kolb, Bryan, et al.
Publicado: (2014)

Harnessing the power of dividing cardiomyocytes
por: Muralidhar, Shalini A., et al.
Publicado: (2013)

Harnessing the power of microbial nanowires
por: Reguera, Gemma
Publicado: (2018)

Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2021)

Strong concordance between RNA structural and single nucleotide variants identified via next generation sequencing techniques in primary pediatric leukemia and patient-derived xenograft samples
por: Barwe, Sonali P., et al.
Publicado: (2020)

The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
por: Zhu, Yu, et al.
Publicado: (2023)

SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
por: Andrades, Alvaro, et al.
Publicado: (2023)

HARNESSING THE POWER OF OLDER AMERICANS: INDEPENDENCE CENTER NETWORKS TO DEVELOP TECHNOLOGIES PROMOTING MOBILITY
por: Hall, Katherine S, et al.
Publicado: (2019)

AYUSH digital initiatives: Harnessing the power of digital technology for India’s traditional medical systems
por: Muthappan, Sendhilkumar, et al.
Publicado: (2022)

Molecular Dynamics Simulation Studies of GLUT4: Substrate-Free and Substrate-Induced Dynamics and ATP-Mediated Glucose Transport Inhibition
por: Mohan, Suma, et al.
Publicado: (2010)

Think twice: harnessing the power of counterintuition
por: Mauboussin, Michael J
Publicado: (2012)

Harnessing solar power: the photovoltaics challenge
por: Zweibel, Ken
Publicado: (1990)

Inescapable data: harnessing the power of convergence
por: Stakutis, Chris, et al.
Publicado: (2005)

Harnessing the power of theorising in implementation science
por: Kislov, Roman, et al.
Publicado: (2019)

Vaccine Vectors Harnessing the Power of Cytomegaloviruses
por: Ynga-Durand, Mario Alberto, et al.
Publicado: (2019)

Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications
por: Chang, Chia-Yu, et al.
Publicado: (2018)

Histone deacetylase inhibitors: clinical implications for hematological malignancies
por: Tambaro, Francesco Paolo, et al.
Publicado: (2010)

A case-control analysis of common variants in GIP with type 2 diabetes and related biochemical parameters in a South Indian population
por: Sugunan, Divya, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4eoqvom74kkfcejrt03nk8ddm5